Impact of dopamine versus serotonin cell transplantation for the development of graft-induced dyskinesia in a rat Parkinson model

Brain Research

Volumn 1470, Issue , 2012, Pages 119-129

  García, Joanna ^a   Carlsson, Thomas ^b,c,d   Döbrössy, Máté ^a   Nikkhah, Guido ^a   Winkler, Christian ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

5 HT; 6 OHDA; Amphetamine induced dyskinesia; Graft induced dyskinesia (GID); L DOPA induced dyskinesia; Parkinson's disease

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DYSKINESIA; FEMALE; GRAFT INDUCED DYSKINESIA; GRAFT SURVIVAL; NONHUMAN; PARKINSON DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL;

ADRENERGIC AGENTS; AMPHETAMINES; ANALYSIS OF VARIANCE; ANIMALS; ANTIPARKINSON AGENTS; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; DYSKINESIAS; FEMALE; FUNCTIONAL LATERALITY; LEVODOPA; NERVE FIBERS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; RNA-BINDING PROTEINS; SEROTONERGIC NEURONS; STATISTICS AS TOPIC; STEREOTYPED BEHAVIOR; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; RATTUS;

EID: 84864628963     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.06.029     Document Type: Article

References (42)

1. M. Abercrombie Estimation of nuclear population from microtome sections Anat. Rec. 94 1946 239 247
2. C. Bédard, M.J. Wallman, E. Pourcher, P.V. Gould, A. Parent, and M. Parent Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea Parkinsonism Relat. Disord. 17 2011 593 598
3. T. Carlsson, C. Winkler, M. Lundblad, M.A. Cenci, A. Björklund, and D. Kirik Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia Neurobiol. Dis. 21 2006 657 668 (Pubitemid 43277547)
4. T. Carlsson, M. Carta, C. Winkler, A. Björklund, and D. Kirik Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease J. Neurosci. 27 2007 8011 8022 (Pubitemid 47173327)
5. T. Carlsson, M. Carta, A. Muñoz, B. Mattsson, C. Winkler, D. Kirik, and A. Björklund Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration Brain 132 2009 319 335
6. M. Carta, T. Carlsson, D. Kirik, and A. Björklund Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats Brain 130 2007 1819 1833 (Pubitemid 47343795)
7. M. Carta, T. Carlsson, A. Muñoz, D. Kirik, and A. Björklund Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease Mov. Disord. 25 Suppl. 1 2010 S174 S179
8. M.A. Cenci, C.S. Lee, and A. Bjorklund L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA Eur. J. Neurosci. 10 1998 2694 2706 (Pubitemid 28362576)
9. M.S. Cho, Y.E. Lee, J.Y. Kim, S. Chung, Y.H. Cho, D.S. Kim, S.M. Kang, H. Lee, M.H. Kim, J.H. Kim, J.W. Leem, S.K. Oh, Y.M. Choi, D.Y. Hwang, J.W. Chang, and D.W. Kim Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells Proc. Natl. Acad. Sci. 105 9 2008 3392 3397 (Pubitemid 351723563)
10. C.R. Freed, P.E. Greene, R.E. Breeze, W.Y. Tsai, W. DuMouchel, R. Kao, S. Dillon, H. Winfield, S. Culver, J.Q. Trojanowski, D. Eidelberg, and S. Fahn Transplantation of embryonic dopamine neurons for severe Parkinsons disease N. Engl. J. Med. 344 2001 710 719 (Pubitemid 32204988)
11. C.R. Freed, R.E. Breeze, S. Fahn, and D. Eidelberg Preoperative response to levodopa is the best predictor of transplant outcome Ann. Neurol. 55 6 2004 896 2004
12. J. García, T. Carlsson, M. Döbrössy, G. Nikkhah, and C. Winkler Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia Neurobiol. Dis. 43 2011 576 587
13. J. García, T. Carlsson, M. Döbrössy, G. Nikkhah, and C. Winkler Extent of pre-operative L-DOPA-induced dyskinesia predicts the severity of graft-induced dyskinesia after fetal dopamine cell transplantation Exp. Neurol. 232 2 2011 270 279
14. J. Graff-Radford, K.D. Foote, R.L. Rodriguez, H.H. Fernandez, R.A. Hauser, A. Sudhyadhom, C.A. Rosado, J.C. Sanchez, and M.S. Okun Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia Arch. Neurol. 63 8 2006 1181 1184 (Pubitemid 44232329)
15. P. Hagell, P. Piccini, A. Björklund, P. Brundin, S. Rehncrona, H. Widner, L. Crabb, N. Pavese, W.H. Oertel, N. Quinn, D.J. Brooks, and O. Lindvall Dyskinesias following neural transplantation in Parkinson's disease Nat. Neurosci. 5 2002 627 628 (Pubitemid 34742975)
16. J. Herzog, O. Pogarell, M.O. Pinsker, A. Kupsch, W.H. Oertel, O. Lindvall, G. Deuschl, and J. Volkmann Deep brain stimulation in Parkinson's disease following fetal nigral transplantation Mov. Disord. 15 23(9) 2008 1293 1296
17. K. Kannari, H. Yamato, H. Shen, M. Tomiyama, T. Suda, and M. Matsunaga Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation J. Neurochem. 76 2001 1346 1353 (Pubitemid 32198239)
18. E.L. Lane, C. Winkler, P. Brundin, and M.A. Cenci The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat Neurobiol. Dis. 22 2006 334 345
19. E.L. Lane, D. Soulet, L. Vercammen, M.A. Cenci, and P. Brundin Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease Neurobiol. Dis. 32 2 2008 220 228
20. E.L. Lane, L. Vercammen, M.A. Cenci, and P. Brundin Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats Exp. Neurol. 1 2009 355 358
21. E.L. Lane, P. Brundin, and M.A. Cenci Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease Neurobiol. Dis. 35 1 2009 42 51
22. E.L. Lane, A. Björklund, S.B. Dunnett, and C. Winkler Neural grafting in Parkinson's disease: unraveling the mechanisms underlying graft-induced dyskinesia Prog. Brain Res. 184 2010 295 309
23. Lane, E.L, Winkler, C. L-DOPA- and graft-induced dyskinesia following transplantation. Prog. Brain Res.; in press.
24. Y. Ma, A. Feigin, V. Dhawan, M. Fukuda, Q. Shi, P. Greene, R. Breeze, S. Fahn, C. Freed, and D. Eidelberg Dyskinesia after fetal cell transplantation for parkinsonism: a PET study Ann. Neurol. 52 2002 628 634 (Pubitemid 35246867)
25. Y. Ma, C. Tang, T. Chaly, P. Greene, R. Breeze, S. Fahn, C. Freed, V. Dhawan, and D. Eidelberg Dopamine cell implantation in Parkinsons disease: long-term clinical and (18) F-FDOPA PET outcomes J. Nucl. Med. 51 2010 7 15
26. E. Maries, J.H. Kordower, Y. Chu, T.J. Collier, C.E. Sortwell, E. Olaru, K. Shannon, and K. Steece-Collier Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats Neurobiol. Dis. 21 2006 165 180 (Pubitemid 41817316)
27. I. Mendez, A. Vinuela, A. Astradsson, K. Mukhida, P. Hallett, H. Robertson, T. Tierney, R. Holness, A. Dagher, J.Q. Trojanowski, and O. Isacson Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years Nat. Med. 14 2008 507 509 (Pubitemid 351655215)
28. A. Muñoz, Q. Li, F. Gardoni, E. Marcello, C. Qin, T. Carlsson, D. Kirik, M. Di Luca, A. Björklund, E. Bezard, and M. Carta Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia Brain 131 Pt 12 2008 3380 3394
29. C.W. Olanow, C.G. Goetz, J.H. Kordower, A.J. Stoessl, V. Sossi, M.F. Brin, K.M. Shannon, G.M. Nauert, D.P. Perl, J. Godbold, and T.B. Freeman A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease Ann. Neurol. 54 2003 403 414 (Pubitemid 37072046)
30. C.W. Olanow, J.H. Kordower, A.E. Lang, and J.A. Obeso Dopaminergic transplantation for Parkinson's disease: current status and future prospects Ann. Neurol. 66 5 2009 591 596
31. M. Politis, K. Wu, C. Loane, N.P. Quinn, D.J. Brooks, S. Rehncrona, A. Björklund, O. Lindvall, and P. Piccini Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants Sci. Transl. Med. 2 38 2010 4 38
32. M. Politis, W.H. Oertel, K. Wu, N.P. Quinn, O. Pogarell, D.J. Brooks, A. Bjorklund, O. Lindvall, and P. Piccini Graft-induced dyskinesias in Parkinson's disease: high striatal serotonin/dopamine transporter ratio Mov. Disord. 26 11 2011 1997 2003
33. D Rylander, M Parent, SS O'Sullivan, S Dovero, AJ Lees, and E Bezard Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia Ann. Neurol. 68 2010 619 628
34. R.B. Rothman, M.H. Baumann, C.M. Dersch, D.V. Romero, K.C. Rice, F.I. Carroll, and J.S. Partilla Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin Synapse 39 1 2001 32 41
35. E. Shin, J. García, C. Winkler, A. Björklund, and M. Carta Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat Parkinsons disease model Neurobiol. Dis. 47 2012 393 406
36. K. Steece-Collier, K.E. Soderstrom, T.J. Collier, C.E. Sortwell, and E. Maries-Lad Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats J. Comp. Neurol. 515 1 2009 15 30
37. K.E. Soderstrom, G. Meredith, T.B. Freeman, S.O. McGuire, T.J. Collier, C.E. Sortwell, Q. Wu, and K. Steece-Collier The synaptic impact of the host immune response in a parkinsonian allograft rat model: influence on graft-derived aberrant behaviors Neurobiol. Dis. 32 2 2008 229 242
38. H. Tanaka, K. Kannari, T. Maeda, M. Tomiyama, T. Suda, and M. Matsunaga Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats NeuroReport 10 1999 631 634 (Pubitemid 29333295)
39. U. Ungerstedt, and G.W. Arbuthnott Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system Brain Res. 24 3 1970 485 493
40. A. Vinuela, P.J. Hallett, C. Reske-Nielsen, M. Patterson, T.D. Sotnikova, M.G. Caron, R.R. Gainetdinov, and O. Isacson Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-DOPA dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease Brain 131 2008 3361 3379
41. S. Wee, K.G. Anderson, M.H. Baumann, R.B. Rothman, B.E. Blough, and W.L. Woolverton Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs J. Pharmacol. Exp. Ther. 313 2 2005 848 854 (Pubitemid 40604187)
42. C. Winkler, D. Kirik, A. Björklund, and M.A. Cenci L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease: relation to motor and cellular parameters of nigrostriatal function Neurobiol. Dis. 10 2002 165 186 (Pubitemid 34775470)